Patent · US Active

Antibodies against factor XII and uses thereof

US9574013B2 · kind B2 · utility

4Cited by
3References
20Claims
0Family size

Assignees

Inventors

Key dates

Filing dateDec 6, 2013
Grant dateFeb 21, 2017
Priority date—
Expiry dateFeb 8, 2034

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/76
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided are antibodies that selectively bind to and inhibit activation of coagulation factor XII. Methods of treatment employing these antibodies are described herein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.